HOME
SCIENCE
Overview
Platform
Pipeline
Suggested Reading
NEWS
CONTACT
HOME
SCIENCE
NEWS
CONTACT
News
JAN 24, 2023
GluBio Therapeutics to Participate in Upcoming Molecular Glue Drug Development Summit
AUG 01, 2022
GluBio Therapeutics Completes Series A+ Financing of $22 Million to Advance the Development of Novel TPD Drugs
MAR 07, 2022
GluBio Therapeutics Raises Nearly $50 Million in Series A Round to Work on Molecular Glue Degraders
MAR 15, 2021
GluBio Therapeutics Announced the Closing of $20 Million Seed Financing Round from Three Founding Investors
MAR 01, 2021
GluBio Therapeutics Was Founded by Two Prominent Leaders in the Field of Targeted Protein Degradation